11-121125583-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005422.4(TECTA):​c.1485A>G​(p.Ala495Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.708 in 1,613,962 control chromosomes in the GnomAD database, including 407,423 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 44421 hom., cov: 33)
Exomes 𝑓: 0.70 ( 363002 hom. )

Consequence

TECTA
NM_005422.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -9.07

Publications

25 publications found
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]
TBCEL-TECTA (HGNC:54857): (TBCEL-TECTA readthrough) Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 11-121125583-A-G is Benign according to our data. Variant chr11-121125583-A-G is described in ClinVar as Benign. ClinVar VariationId is 45315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.921 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECTANM_005422.4 linkc.1485A>G p.Ala495Ala synonymous_variant Exon 8 of 24 ENST00000392793.6 NP_005413.2 O75443
TBCEL-TECTANM_001378761.1 linkc.2442A>G p.Ala814Ala synonymous_variant Exon 14 of 30 NP_001365690.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECTAENST00000392793.6 linkc.1485A>G p.Ala495Ala synonymous_variant Exon 8 of 24 5 NM_005422.4 ENSP00000376543.1 O75443
TECTAENST00000264037.2 linkc.1485A>G p.Ala495Ala synonymous_variant Exon 7 of 23 1 ENSP00000264037.2 O75443
TECTAENST00000642222.1 linkc.1485A>G p.Ala495Ala synonymous_variant Exon 8 of 24 ENSP00000493855.1 A0A2R8YDL0

Frequencies

GnomAD3 genomes
AF:
0.756
AC:
114975
AN:
152124
Hom.:
44364
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.928
Gnomad AMI
AF:
0.624
Gnomad AMR
AF:
0.672
Gnomad ASJ
AF:
0.611
Gnomad EAS
AF:
0.674
Gnomad SAS
AF:
0.734
Gnomad FIN
AF:
0.724
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.692
Gnomad OTH
AF:
0.744
GnomAD2 exomes
AF:
0.703
AC:
176656
AN:
251170
AF XY:
0.704
show subpopulations
Gnomad AFR exome
AF:
0.936
Gnomad AMR exome
AF:
0.618
Gnomad ASJ exome
AF:
0.625
Gnomad EAS exome
AF:
0.674
Gnomad FIN exome
AF:
0.729
Gnomad NFE exome
AF:
0.697
Gnomad OTH exome
AF:
0.704
GnomAD4 exome
AF:
0.703
AC:
1027389
AN:
1461720
Hom.:
363002
Cov.:
97
AF XY:
0.704
AC XY:
511674
AN XY:
727158
show subpopulations
African (AFR)
AF:
0.942
AC:
31525
AN:
33480
American (AMR)
AF:
0.623
AC:
27852
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.622
AC:
16253
AN:
26136
East Asian (EAS)
AF:
0.682
AC:
27060
AN:
39694
South Asian (SAS)
AF:
0.721
AC:
62205
AN:
86258
European-Finnish (FIN)
AF:
0.736
AC:
39230
AN:
53308
Middle Eastern (MID)
AF:
0.704
AC:
4062
AN:
5768
European-Non Finnish (NFE)
AF:
0.698
AC:
776418
AN:
1111964
Other (OTH)
AF:
0.708
AC:
42784
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
21033
42065
63098
84130
105163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19696
39392
59088
78784
98480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.756
AC:
115079
AN:
152242
Hom.:
44421
Cov.:
33
AF XY:
0.755
AC XY:
56178
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.928
AC:
38577
AN:
41550
American (AMR)
AF:
0.672
AC:
10275
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.611
AC:
2119
AN:
3470
East Asian (EAS)
AF:
0.674
AC:
3489
AN:
5174
South Asian (SAS)
AF:
0.734
AC:
3536
AN:
4820
European-Finnish (FIN)
AF:
0.724
AC:
7681
AN:
10608
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.692
AC:
47056
AN:
68004
Other (OTH)
AF:
0.742
AC:
1565
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1409
2819
4228
5638
7047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.707
Hom.:
25127
Bravo
AF:
0.757
Asia WGS
AF:
0.725
AC:
2522
AN:
3478
EpiCase
AF:
0.689
EpiControl
AF:
0.690

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala495Ala in Exon 07 of TECTA: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 31.0% (2176/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs536069). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal recessive nonsyndromic hearing loss 21 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 12 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.034
DANN
Benign
0.22
PhyloP100
-9.1
Mutation Taster
=83/17
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs536069; hg19: chr11-120996292; COSMIC: COSV50687976; COSMIC: COSV50687976; API